Detalhe da pesquisa
1.
Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer.
Lung Cancer;
139: 60-67, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31739184
2.
A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors.
Cancer Chemother Pharmacol;
77(5): 997-1003, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27025608
3.
Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
Transpl Immunol;
13(3): 191-200, 2004 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15381202
4.
CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity.
Cancer Res;
70(9): 3647-56, 2010 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20388807
5.
The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action.
Cancer Res;
67(23): 11359-67, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18056463
6.
Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats.
Xenotransplantation;
10(3): 240-51, 2003 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12694544